
Daniel C. Danila, MD Medical Oncology Fellow
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Daniel C. Danila discloses the following relationships and financial interests:
-
ANGLE plc
Provision of Services -
AstraZeneca
Provision of Services -
Aximmune
Provision of Services (uncompensated) -
OncLive
Provision of Services
-
Pfizer, Inc.
Provision of Services -
Sanador
Provision of Services (uncompensated) -
Targeted Oncology
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures